COVID-19 growth after 100 cases select countries worldwide 2020| ��ƽ��

Cumulative number of coronavirus (COVID-19) cases in select countries worldwide as of March 11, 2020, by number of days after reaching 100 cases

Number of days since reaching 100 cases	Germany	France	Spain	U.S.	Singapore	Italy	South Korea	Japan	Switzerland	Austria	UK
1	150	100	114	108	102	124	156	132	86	102	114
2	188	100	151	129	106	229	346	144	227	112	160
3	240	191	200	148	108	374	556	144	264	131	206
4	349	212	365	213	110	528	763	157	332	182	271
5	534	282	374	213	112	650	893	164	332	-	321
6	639	420	589	213	117	888	1,146	186	645	-	373
7	847	613	589	472	130	1,100	1,595	210	-	-	456
8	1,112	939	1,024	987	138	1,700	2,022	230	-	-	-
9	1,139	1,100	2,140	-	150	2,000	2,931	239	-	-	-
10	1,567	1,412	-	-	160	2,502	3,526	254	-	-	-
11	-	2,269	-	-	166	3,089	4,212	268	-	-	-
12	-	-	-	-	178	3,858	4,812	287	-	-	-
13	-	-	-	-	-	4,636	5,328	320	-	-	-
14	-	-	-	-	-	5,883	5,766	349	-	-	-
15	-	-	-	-	-	7,400	6,284	408	-	-	-
16	-	-	-	-	-	9,172	6,767	455	-	-	-
17	-	-	-	-	-	12,462	7,134	488	-	-	-
18	-	-	-	-	-	-	7,382	514	-	-	-
19	-	-	-	-	-	-	7,513	620	-	-	-
20	-	-	-	-	-	-	7,869	-	-	-	-
21	-	-	-	-	-	-	-	-	-	-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Release date

March 2020

More information

Region

Worldwide

Survey time period

as of March 11, 2020

Supplementary notes

Note that China has not been included due to the extended length of time since the country reported over 100 cases and the high number of cases since then.

Citation formats

Italy experienced a sharp rise in the number of positive infections shortly after confirming its 100th coronavirus case. In the space of just 17 days, the number of cases in Italy had soared to more than 12,000. In comparison, the spread of the virus was much slower in Japan.

The COVID-19 outbreak in Italy

Italy was the first European nation to be severely impacted by COVID-19. There had been approximately 35,400 coronavirus-related deaths recorded in the country as of August 17, 2020. Following a two-month lockdown period, restrictions in Italy were eased in early May, and citizens are now permitted to travel between regions and abroad. However, the risk of a resurgence remains, and the country’s state of emergency has been extended until October 15, 2020. It is looking increasingly likely that restrictions will not be completely lifted until a vaccine for the disease is discovered.

Pfizer confident of vaccine success

Pfizer and BioNTech are jointly developing one candidate vaccine that is under clinical evaluation. In July 2020, the two companies announced an agreement with the U.S. government that will bring millions of doses to the American people. The BNT162 mRNA-based vaccine is currently being produced even though it has not received regulatory approval from the FDA. This is a risky approach and is one that could cost the companies millions of dollars should the vaccine be rejected. However, if regulatory approval is received, the safe and effective vaccine can be shipped quickly.